$PRAN Headlines Prana Biotechnology up 19% in premarket

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$PRAN Headlines

Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy
What is Alzheimer’s? 11:29 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Help could be on the way for Alzheimer's 9:47 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Elan, Wyeth sink on Alzheimer's study 12:38 p.m. July 30, 2008 - Val Brickates Kennedy
Baidu.com shares end lower; Novo Nordisk downgraded 5:32 p.m. Feb. 26, 2008 - Carla Mozee
Friday's biggest stock gainers and decliners 5:28 p.m. Oct. 13, 2006 - MarketWatch
Prana Biotech gets 'going concern' notice from auditors 7:41 a.m. Oct. 13, 2006 - Thomas Middleton
Prana Biotech gets "going concern" auditors notice 7:36 a.m. Oct. 13, 2006 - Thomas Middleton
Prana to begin Phase II trial of PBT2 drug in Q4 12:03 p.m. July 24, 2006 - Michael Baron
Prana shares up; co. developing PBT2 Alzheimer's treatment 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech volume 452,583 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech shares soar 70% to $2.80 12:03 p.m. July 24, 2006 - Michael Baron


Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher 9:54 a.m. Jan. 25, 2014 - Seeking Alpha
Prana Biotechnology Faces Major Upcoming Catalysts 9:59 a.m. Jan. 24, 2014 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Prana Biotech 8:21 a.m. Jan. 24, 2014 - TheStreet.com
Alzheimer’s Stocks Are a Stealth Opportunity 3:50 a.m. Dec. 10, 2013 - InvestorPlace.com
Given Imaging – Why Is GIVN Stock Soaring? 6:42 a.m. Dec. 9, 2013 - InvestorPlace.com
Phase II Results Approaching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
Phase II Results Approching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 10:48 a.m. Nov. 1, 2013 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 3:00 a.m. Aug. 21, 2013 - InvestorPlace.com
Still Time To Catch Big Growth In Biotech: George Zavoico 5:12 p.m. Aug. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 3:00 a.m. July 31, 2013 - InvestorPlace.com
Prana Completes Phase 2 Huntington Disease Trial With PBT2 7:10 a.m. July 23, 2013 - benzinga.com
Prana Announces Share Purchase Plan Closed 7:05 a.m. May 3, 2013 - benzinga.com
4 Healthcare Stock Stories Not To Be Overlooked 3:36 p.m. March 7, 2013 - Wall St. Cheat Sheet
Seven Highly Unusual Volume Spikes (BYD, MTG, NS, PANW, PRAN, SCSS, SSYS) 10:02 a.m. March 4, 2013 - 247WallSt.com
2 Speculative Biotech Stocks To Consider In The Wake Of Early-Stage Developments 3:52 p.m. Dec. 13, 2012 - Seeking Alpha
7 Innovative Biotechs That Could Soar By Year-End: George Zavoico 3:00 p.m. Sept. 13, 2012 - Seeking Alpha
Elan's Split Will Create 2 Very Different Companies 2:12 p.m. Aug. 14, 2012 - Seeking Alpha
Stock Analysis Recap: Here’s Why These Stocks Trended This Week 1:11 p.m. Nov. 27, 2011 - Wall St. Cheat Sheet


Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 9:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 9:02 a.m. Dec. 9, 2013 - Marketwire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Prana's PBT2 Featured as a Top 10 Global Neuroscience Project 9:02 a.m. Nov. 19, 2013 - Marketwire
Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease 9:02 a.m. Nov. 18, 2013 - Marketwire
Prana Responds to Media Segment Under ASX Guidance Note 8 9:01 a.m. Nov. 15, 2013 - Marketwire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Prana's PBT2 Reverses Memory Loss in Normal Aging 9:07 a.m. Oct. 30, 2013 - Marketwire
Five Star Equities Issues New Research Reports on DSX, LAKE, PRAN and SWY 8:00 a.m. Sept. 16, 2013 - ACCESSWIRE
Prana Updates Progress on PBT2 Trials in Alzheimer's and Huntington's Diseases 8:01 a.m. Sept. 13, 2013 - Marketwire
Parkinson's UK Awards GBP 150,000 to Study Prana's PBT434 8:03 a.m. Sept. 4, 2013 - Marketwire
Five Star Equities Issues New Research Reports on ARQL, CYTK, HALO and PRAN 7:41 a.m. Sept. 4, 2013 - ACCESSWIRE
Prana Drug Treatment PBT2 Named One of Top Neuroscience Projects to Watch 8:02 a.m. Sept. 3, 2013 - Marketwire
Prana Prepares for Next Steps in the PBT2 Development Path to Market and Commercialization With Key Appointments Strategy 9:11 a.m. Aug. 1, 2013 - Marketwire
Five Star Equities Issues New Research Reports on HAE, PRAN, PRGO and SNTA 7:41 a.m. July 30, 2013 - ACCESSWIRE
Prana Doses First Patient in PBT2 Alzheimer's Extension Study 8:02 a.m. July 29, 2013 - Marketwire
Prana Completes Phase 2 Huntington Disease Trial With PBT2 8:03 a.m. July 23, 2013 - Marketwire
Prana Receives Approval for 12-Month Open-Label Extension Study in Alzheimer's Disease 8:30 a.m. July 3, 2013 - Marketwire
PBT434 Drug Candidate Shows Potential as "Next-Generation" Disease-Modifying Treatment in Parkinson's Disease 8:02 a.m. June 20, 2013 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Geron Corporation Strengthens Leadership Team to Drive Growth

Updated Category News Views 225

Geron Corporation Revamps Leadership to Enhance Growth Foster City, CA — Geron Corporation (Nasdaq: GERN), recognized for its commitment to transforming the lives of patients coping with blood cancer, has unveiled a series of executive changes aimed at fine-tuning its leadership to better reflect its ambitious strategic objectives. Among these changes, Dr. Andrew...

Continue Reading
GreenTree Hospitality Declares Dividend and Updates Shareholder Program

Updated Category News Views 133

GreenTree Hospitality Group Declares Cash Dividend GreenTree Hospitality Group Ltd. (NYSE: GHG), a prominent hospitality management company based in China, has recently made headlines by announcing a cash dividend of US$0.06 per ordinary share. This decision was approved by the board of directors, marking a significant commitment to rewarding its shareholders. Dividend...

Continue Reading
Anil Kapur Joins Nurix Therapeutics Board of Directors

Updated Category News Views 200

Nurix Therapeutics Welcomes Anil Kapur to Its Board Nurix Therapeutics, Inc. (NASDAQ: NRIX), a company dedicated to advancing therapies for cancer and inflammatory diseases, is thrilled to announce the addition of Anil Kapur to its board of directors. This appointment marks a significant step as the company prepares to enhance its leadership team. With an extensive...

Continue Reading
U.S. Postal Service Shows Positive Financial Progress

Updated Category News Views 159

U.S. Postal Service Reports Financial Results The U.S. Postal Service has recently shared its financial results for the fiscal year. Notable accomplishments include reducing the controllable loss by $434 million compared to the previous fiscal year. Additionally, operating revenue increased by $1.4 billion, reaching a total of $79.5 billion. This growth is largely...

Continue Reading
Canada Foundation for Innovation Investments Boost Research Capacity

Updated Category News Views 171

Investment in Research Infrastructure through CFI OTTAWA, Ontario – The Government of Canada has recently unveiled a significant investment of nearly $4.4 million in research infrastructure through the Canada Foundation for Innovation (CFI) to support 17 Canada Research Chairs (CRCs) across 12 universities. This funding aims to strengthen Canada's position as a hub for...

Continue Reading